APP and Hypertension: Hypertension in APP/PS1 mice accelerates progression of AD-like pathologies, including cognitive dysfunction and amyloid pathology, in addition to reduced density of microvessels and cerebrovascular dysfunction (Cifuentes et al., 2015).